STAT

‘We have entered a new era’: Cancer researchers no longer follow a single path to discovery

At a STAT panel, experts highlighted the tantalizing ways in which scientists hope to make progress against cancer, even as steep challenges remain.
Prostate cancer cells seen under the microscope.

CAMBRIDGE, Mass. — Blocking tumor progression. Developing liquid biopsies. Engaging patients to find personalized treatments.

They are all tantalizing ways in which scientists hope to make progress against cancer, a panel of experts noted Wednesday, even as steep challenges remain and the conversation around treatment evolves.

“We have entered a new era,” said Tyler

You’re reading a preview, subscribe to read more.

More from STAT

STAT1 min readIntelligence (AI) & Semantics
STAT+: Q&A: Defining Responsible AI In Health Care, With CHAI CEO Brian Anderson
CHAI CEO Anderson wants to build public trust in AI and empower patients and providers to have more informed conversations.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Approval For Sarepta Drug, MSF Closing Access Campaign And More
After months of haggling, Vertex Pharmaceuticals and the National Health Service in England reached agreement over access to several cystic fibrosis treatments, capping an end to a controversial, long-running saga:
STAT2 min read
STAT+: Pharmalittle: We’re Reading About EMA Plans For GLP-1 Shortages, Walgreens Store Closings, And More
The European Medicines Agency and member countries announced several steps to address shortages of GLP-1 drugs.

Related